Two pharmaceutical companies have been fined more than £260m by the UK’s competition watchdog after the pair colluded to overcharge the NHS for almost a decade.
Two drug companies fined £260m for swindling NHS over ‘life-saving medicines’
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.